Sherwin Sattarzadeh
About Sherwin Sattarzadeh
Sherwin Sattarzadeh at Blueprint Medicines
Sherwin Sattarzadeh joined Blueprint Medicines in September 2015 as Senior Director, Head of Regulatory Affairs. He spearheaded the regulatory strategy and execution from the start of development to the U.S. and EU approvals for the company's two marketed medicines. His successful leadership in regulatory affairs led to his promotion to Vice President in February 2018. In March 2020, he transitioned to the role of Chief of Staff while continuing his responsibilities. In this role, he played a critical part in helping the company navigate through significant growth during the global pandemic.
Sherwin Sattarzadeh's Career in Regulatory Affairs
Before joining Blueprint Medicines, Sherwin Sattarzadeh held roles of increasing responsibility in the regulatory affairs teams of Genzyme, Titan Pharmaceuticals, and Genelabs Technologies. His extensive experience in regulatory affairs includes leading teams and developing strategies for successful product approvals in competitive markets. This background provided him with a solid foundation for his subsequent achievements at Blueprint Medicines.
Education and Expertise of Sherwin Sattarzadeh
Sherwin Sattarzadeh has a diverse educational background that combines science and business. He earned a B.Sc. in Chemistry from the University of British Columbia, grounding him in the scientific and technical aspects of the pharmaceutical industry. Additionally, he holds an MBA in Finance from Boston University, equipping him with the financial acumen necessary for strategic decision-making in a senior leadership role.
Regulatory Strategy Achievements of Sherwin Sattarzadeh
Sherwin Sattarzadeh is known for successfully leading the regulatory strategy and execution for Blueprint Medicines' marketed medicines. He managed the regulatory processes from development initiation to achieving U.S. and EU approvals. This accomplishment marked significant milestones for the company and demonstrated his expertise and leadership in the field of regulatory affairs.